- Home
- STG vs AVTX Comparison
STG vs AVTX Comparison
Compare STG & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STG | AVTX |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.1M | 801.8M |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | STG | AVTX |
|---|---|---|
| Price | $2.78 | $13.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $44.08 |
| AVG Volume (30 Days) | 6.1K | ★ 1.0M |
| Earning Date | 11-19-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.10 | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $2.44 | $12.51 |
| 52 Week High | $8.20 | $24.27 |
Technical Indicators
Market Signals| Indicator | STG | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.05 | 27.91 |
| Support Level | $2.61 | $12.98 |
| Resistance Level | $3.62 | $15.27 |
| Average True Range (ATR) | 0.08 | 0.88 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 0.00 | 10.10 |
Price Performance
Historical ComparisonAbout STG Sunlands Technology Group
Sunlands Technology Group operates in China's adult online education market and adult personal interest learning market through its online platforms. The Group has a deep understanding of the educational needs of its prospective students and offers solutions to help them achieve their goals. It provides online professional courses and educational content, including interest, professional skills, professional certification preparation courses, and degree- or diploma-oriented post-secondary courses. The Group adopts a counseling-oriented sales and marketing approach to offer education solutions based on students' backgrounds and goals, delivering adult online education and personal interest learning through extensive course and content offerings.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.